Single cell heterogeneity
Authors:
- Steven D HorneSHSteven D Horne
- Joshua B StevensJSJoshua B Stevens
- Guo LiuGLGuo Liu
- Andrew Y YingAYAndrew Y Ying
- Barbara VanderhydenBVBarbara Vanderhyden
- Stephen A KrawetzSKStephen A Krawetz
- Root GorelickRGRoot Gorelick
- Henry Hq HengHenry Hq Heng
- 1 December 2013
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 12 (23) , 3640-3649
Abstract
Multi-level heterogeneity is a fundamental but underappreciated feature of cancer. Most technical and analytical methods either completely ignore heterogeneity or do not fully account for it, as heterogeneity has been considered noise that needs to be eliminated. We have used single-cell and population-based assays to describe an instability-mediated mechanism where genome heterogeneity drastically affects cell growth and cannot be accurately measured using conventional averages. First, we show that most unstable cancer cell populations exhibit high levels of karyotype heterogeneity, where it is difficult, if not impossible, to karyotypically clone cells. Second, by comparing stable and unstable cell populations, we show that instability-mediated karyotype heterogeneity leads to growth heterogeneity, where outliers dominantly contribute to population growth and exhibit shorter cell cycles. Predictability of population growth is more difficult for heterogeneous cell populations than for homogenous cell populations. Since "outliers" play an important role in cancer evolution, where genome instability is the key feature, averaging methods used to characterize cell populations are misleading. Variances quantify heterogeneity; means (averages) smooth heterogeneity, invariably hiding it. Cell populations of pathological conditions with high genome instability, like cancer, behave differently than karyotypically homogeneous cell populations. Single-cell analysis is thus needed when cells are not genomically identical. Despite increased attention given to single-cell variation mediated heterogeneity of cancer cells, continued use of average-based methods is not only inaccurate but deceptive, as the "average" cancer cell clearly does not exist. Genome-level heterogeneity also may explain population heterogeneity, drug resistance, and cancer evolution.Keywords
This publication has 55 references indexed in Scilit:
- Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cellsCancer and Metastasis Reviews, 2013
- PrefaceCytogenetic and Genome Research, 2013
- Why imatinib remains an exception of cancer researchJournal of Cellular Physiology, 2012
- Variability of Our Somatic (Epi)GenomesScience, 2010
- Genome based cell population heterogeneity promotes tumorigenicity: The evolutionary mechanism of cancerJournal of Cellular Physiology, 2008
- Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changesExperimental Cell Research, 2007
- Cancer progression by non‐clonal chromosome aberrationsJournal of Cellular Biochemistry, 2006
- Clonal and non-clonal chromosome aberrations and genome variation and aberrationGenome, 2006
- Phenotypic Diversity, Population Growth, and Information in Fluctuating EnvironmentsScience, 2005
- Bacterial Persistence as a Phenotypic SwitchScience, 2004